Clinical thyroid testing company ThyroMetrix (Williamsburg, VA) has partnered with photonics-based mobile diagnostics developer Holomic LLC (Los Angeles, CA) for the Holomic Rapid Diagnostic Reader (HRDR-200) for smartphones, which works in sync with ThyroMetrix's ThyroTest thyroid stimulating hormone (TSH) blood test available in the U.S. and Canada.
ThyroTest, an FDA-regulated and Clinical Laboratory Improvement Amendments (CLIA)-waived rapid immunoassay test, was developed for in-office thyroid diagnosing using a single drop of blood on a small test card. When coupled with the HRDR-200, the result is an inexpensive, portable TSH mobile diagnostic test that enables immediate diagnosis of thyroid disorders.
A drop of blood on the ThyroTest card inserted into the HRDR-200, which is attached to the existing camera unit of a smartphone, can be imaged under LED-based illumination in a special optical interface. Captured raw images are digitally processed through a smartphone application to reveal test results immediately.
Holomic, LLC is a finalist in the Nokia Sensing XCHALLENGE, a global competition that identifies breakthroughs in health sensing technology. ThyroMetrix is supporting their entry in the competition by providing testing services through their ThyroScore program of which Holomic is a sponsor. Following successful trials and FDA approval, Holomic's innovative technology will be incorporated into the ThyroMetrix Diagnostic System for rapid point-of-care testing.